Press "Enter" to skip to content

Glenmark, Torrent Pharma ink licensing pact to co-market diabetes drug in India

"Glenmark will manufacture and supply Remogliflozin while Torrent will market the drug under its own trademark ‘Zucator’ in India," Glenmark Pharma said in a regulatory filing.

Original source:

Also Read:   Sanofi joins forces with U.S. to advance a novel coronavirus vaccine